Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)

Accolade Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,446	14,369	20,911	36,132	31,104	26,551
Market Cap Growth	-45.20%	-31.28%	-42.13%	16.16%	17.15%	222.07%
Enterprise Value	10,552	12,194	20,036	35,498	30,383	26,037
Last Close Price	101.50	113.50	184.50	319.50	279.64	240.11
PS Ratio	363.65	448.48	1105.50	31611.24	27212.59	31874.31
PB Ratio	4.21	4.64	15.94	26.31	31.50	23.74
P/TBV Ratio	4.20	4.63	15.90	25.96	32.04	24.29
EV/Sales Ratio	-	380.58	1059.26	31056.74	26581.68	31256.89
Debt / Equity Ratio	0.04	0.04	0.06	0.10	0.12	0.03
Asset Turnover	0.01	0.01	0.01	0.00	0.00	0.00
Inventory Turnover	3.04	3.01	1.27	-	-	-
Quick Ratio	13.03	12.27	7.58	5.80	5.34	18.67
Current Ratio	14.29	13.36	8.86	6.99	5.95	19.05
Return on Equity (ROE)	-3.66%	-4.17%	-7.54%	-24.75%	-12.34%	-10.95%
Return on Assets (ROA)	-4.27%	-4.14%	-5.31%	-11.66%	-6.36%	-7.41%
Return on Capital (ROIC)	-4.52%	-4.39%	-5.74%	-12.45%	-6.69%	-7.83%
Earnings Yield	-0.55%	-0.57%	-0.44%	-0.81%	-0.39%	-0.35%
FCF Yield	-2.17%	-2.04%	-0.53%	-0.66%	-0.70%	-0.44%
Buyback Yield / Dilution	-9.15%	-6.64%	-1.92%	-1.44%	-4.87%	-1.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.